<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02424097</url>
  </required_header>
  <id_info>
    <org_study_id>GCAmerica-WS</org_study_id>
    <nct_id>NCT02424097</nct_id>
  </id_info>
  <brief_title>MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study</brief_title>
  <acronym>GC-WS</acronym>
  <official_title>MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical study is to evaluate the efficacy of multiple applications of
      MI Varnish in combination with MI Paste Plus in caries protection and remineralization in
      comparison to the use of a control (Crest 1,100ppm Fluoride tooth paste, Fluoride rinse
      recommendation) in orthodontic patients in a randomized, single blind, prospective,
      controlled clinical trial over 12 months.

      The effect will be measured by white spot lesion regression and prevention as lesion count.
      Lesions will be scored using the Enamel Decalcification Index (EDI) area evaluation scheme
      (primary outcome), International Caries Detection and Assessment System (ICDAS), the caries
      lesion activity criteria (Nyvad criteria; Bente Nyvad, Scandinavian Researcher), and
      Quantitative Light Fluorescence (QLF, Inspektor Pro, Netherlands)/SOPROLIFE (SOPROLIFE
      fluorescence camera system, Acteon, France) evaluation in maxillary and mandibular anterior
      teeth with orthodontic brackets in treatment and control groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is designed as randomized, single blind, prospective, clinical trial over 12
      months. The subjects for this study will be recruited from the University of California at
      San Francisco UCSF, School of Dentistry, Orthodontic Clinic.

      Participants in the study will be patients, who are in orthodontic treatment or will start
      orthodontic treatment; subjects must have full fixed appliances, with brackets bonded to the
      buccal surfaces of the maxillary and mandibular incisors, canines and first bicuspids.
      Subjects will be of moderate or high caries risk according to Caries Risk Assessment and ATP
      (Adenosine triphosphate) bacteria testing. Subjects will present with at least two active
      white spot lesions on his/her anterior teeth at the start of the study. The age limitation is
      â‰¥ 11 years.

      The subjects will be randomly assigned to 1) Experimental group: MI Varnish and MI Paste Plus
      or 2) Control standard of care group: 1,100 ppm Fluoride tooth paste and recommendation to
      use OTC (Over-the-counter) Fluoride-rinse in the evening at home.

      The clinical study investigator will evaluate the labial/buccal surfaces of upper and lower
      anterior teeth (first bicuspid to first bicuspid) for white spot lesions (WSL) at baseline
      and at the end of 3, 6, and 12 months. Newly formed lesions and changes in existing white
      spot lesions will be documented (using Enamel Decalcification Index (EDI), ICDAS II, light
      digital photographs and blue fluorescence photography SOPROLIFE and QLF- Quantitative Light
      Fluorescence).

      All subjects will receive one professional tooth cleaning at baseline and at each other
      evaluation office visit to allow WSL evaluation (cleaning with ultrasonic device, and
      prophylaxis brush) and treatment application.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in white spot lesions count</measure>
    <time_frame>Baseline and 12-months</time_frame>
    <description>the area evaluation scheme of the Enamel Decalcification Index (EDI) dividing the buccal surface of each tooth into 4 quadrants and registering the possible existence of a lesion in each quadrant allows a WSL count;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in International Caries Detection and Assessment System (ICDAS II) to score for smooth surfaces WSL</measure>
    <time_frame>Baseline and 12-months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in lesion activity, Nyvad criteria</measure>
    <time_frame>Baseline and 12-months</time_frame>
    <description>WS lesion activity will be determined using the Nyvad criteria;</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in SOPROLIFE</measure>
    <time_frame>Baseline and 12-months</time_frame>
    <description>fluorescence measurements using blue light fluorescence make WSLs visible for scoring;</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Quantitative Light Fluorescence (QLF)</measure>
    <time_frame>Baseline and 12-months</time_frame>
    <description>Quantitative Light Fluorescence will be used to evaluate the WSL</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Dental White Spots</condition>
  <condition>Dental Caries</condition>
  <arm_group>
    <arm_group_label>MI Paste &amp; MI Varnish</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MI past will be applied by the patient every night; MI varnish will be applied every three months in the office</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will use at home regal toothpaste every night and F-mouth rinse as recommended</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CPP-ACP 5% sodium fluoride varnish &amp; 900ppm fluoride paste</intervention_name>
    <description>MI Paste &amp; MI Varnish- in-office:
varnish application once every 3 months; at baseline, at the end of month 3, 6, and 9 (4 applications)
- at-home: brushing with regular 1,100ppm F-toothpaste, 2x per day and MI Paste Plus, home application after brushing in the evening; 3-5 minutes with in-home application tray</description>
    <arm_group_label>MI Paste &amp; MI Varnish</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1,100pm F-toothpaste and 0.5%NaF rinse</intervention_name>
    <description>Standard of care at-home:
Crest tooth brushing 2x per day - (recommendation OTC Fluoride-rinse in the evening at home 1x per day)</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 11 or older,

          -  good health,

          -  either gender

          -  present with at least two active white spot lesions on his/her anterior teeth at the
             start of the study

          -  have a moderate or high caries risk according to CAMBRA (Caries Management By Risk
             Assessment) rules

          -  require at least 12 additional months of full fixed appliance therapy from the time
             they are recruited for the study

          -  able to cooperate for treatment in the dental chair and follow at-home instructions

          -  have an understanding of the study

          -  willing to comply with all study procedures and protocols

          -  patient participant is able to provide written informed consent in English; if the
             participant is a minor, the parent/guardian is able to provide written informed
             consent in English and the patient participant is able to provide written assent in
             English

          -  patient participant or if a minor, the parent/guardian, is willing to sign the
             &quot;Authorization for Release of Personal Health Information and Use of Personally
             Unidentified Study Data for Research&quot; form; data will only be used for research

          -  verifiable records of bonding with Transbond Plus Self-Etching Primer (3M Unitek,
             Monrovia, CA) and Transbond Light Cure Adhesive or similar products

          -  verifiable records that &quot;ProSeal&quot; has not been applied at any time during the
             orthodontic treatment

        Exclusion Criteria:

          -  untreated cavitated lesions

          -  extensive composite fillings on buccal surfaces of front teeth/first bicuspids or more
             than one dental crown on front teeth/first bicuspids

          -  has sealants or fluoride releasing cements on the buccal surface of the anterior teeth

          -  in-office fluoride treatment in the last three months

          -  history of using any products containing CCP-ACP (casein phosphopeptides and amorphous
             calcium phosphate; MI paste, chewing gums or candies, etc.), prescription Fluoride
             products, and Chlorhexidine use in the last three months

          -  intrinsic or extremely heavy extrinsic staining

          -  any signs of fluorosis in the dentition

          -  any signs of morphologic/anatomical/developmental deviations in the teeth

          -  previous history of in office bleaching treatment

          -  subject not willing to stop the use of any other oral hygiene product than those
             prescribed/suggested

          -  has underlying systemic disease which could alter enamel composition or formation

          -  suffering from systemic diseases, significant past or medical history with conditions
             that may affect oral health or oral flora (i.e. diabetes, HIV, heart conditions that
             require antibiotic prophylaxis)

          -  use of medication causing dry mouth (extreme high caries risk)

          -  subject is pregnant or lactating

          -  milk protein allergy

          -  any illness/condition that the investigator feels will affect the study outcome

          -  will leave the area and will not be available for recall visits

          -  subjects who are not willing to inform us about prospective visits of other dentist
             and will not allow us to discuss treatment with those dentist

          -  subjects who are not willing to refrain from any additional professional tooth
             cleaning or any additional Fluoride application.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Rechmann, DMD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF School of Dentistry - Dental Offices in Bay Area</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Mitchell L. Decalcification during orthodontic treatment with fixed appliances--an overview. Br J Orthod. 1992 Aug;19(3):199-205. Review.</citation>
    <PMID>1390575</PMID>
  </results_reference>
  <results_reference>
    <citation>Geiger AM, Gorelick L, Gwinnett AJ, Griswold PG. The effect of a fluoride program on white spot formation during orthodontic treatment. Am J Orthod Dentofacial Orthop. 1988 Jan;93(1):29-37.</citation>
    <PMID>3276146</PMID>
  </results_reference>
  <results_reference>
    <citation>Richter AE, Arruda AO, Peters MC, Sohn W. Incidence of caries lesions among patients treated with comprehensive orthodontics. Am J Orthod Dentofacial Orthop. 2011 May;139(5):657-64. doi: 10.1016/j.ajodo.2009.06.037.</citation>
    <PMID>21536209</PMID>
  </results_reference>
  <results_reference>
    <citation>Magness WS, Shannon IL, West DC. Office-applied fluoride treatments for orthodontic patients. J Dent Res. 1979 Apr;58(4):1427.</citation>
    <PMID>285114</PMID>
  </results_reference>
  <results_reference>
    <citation>Stratemann MW, Shannon IL. Control of decalcification in orthodontic patients by daily self-administered application of a water-free 0.4 per cent stannous fluoride gel. Am J Orthod. 1974 Sep;66(3):273-9.</citation>
    <PMID>4528489</PMID>
  </results_reference>
  <results_reference>
    <citation>Mizrahi E. Surface distribution of enamel opacities following orthodontic treatment. Am J Orthod. 1983 Oct;84(4):323-31.</citation>
    <PMID>6605091</PMID>
  </results_reference>
  <results_reference>
    <citation>Gorelick L, Geiger AM, Gwinnett AJ. Incidence of white spot formation after bonding and banding. Am J Orthod. 1982 Feb;81(2):93-8.</citation>
    <PMID>6758594</PMID>
  </results_reference>
  <results_reference>
    <citation>Zachrisson BU, Zachrisson S. Caries incidence and oral hygiene during orthodontic treatment. Scand J Dent Res. 1971;79(6):394-401.</citation>
    <PMID>5288673</PMID>
  </results_reference>
  <results_reference>
    <citation>Gorton J, Featherstone JD. In vivo inhibition of demineralization around orthodontic brackets. Am J Orthod Dentofacial Orthop. 2003 Jan;123(1):10-4.</citation>
    <PMID>12532056</PMID>
  </results_reference>
  <results_reference>
    <citation>Zachrisson BU. Fluoride application procedures in orthodontic practice, current concepts. Angle Orthod. 1975 Jan;45(1):72-81.</citation>
    <PMID>1054935</PMID>
  </results_reference>
  <results_reference>
    <citation>Geiger AM, Gorelick L, Gwinnett AJ, Benson BJ. Reducing white spot lesions in orthodontic populations with fluoride rinsing. Am J Orthod Dentofacial Orthop. 1992 May;101(5):403-7.</citation>
    <PMID>1590288</PMID>
  </results_reference>
  <results_reference>
    <citation>Benson PE, Parkin N, Millett DT, Dyer FE, Vine S, Shah A. Fluorides for the prevention of white spots on teeth during fixed brace treatment. Cochrane Database Syst Rev. 2004;(3):CD003809. Review. Update in: Cochrane Database Syst Rev. 2013;12:CD003809.</citation>
    <PMID>15266503</PMID>
  </results_reference>
  <results_reference>
    <citation>Ã˜gaard B, Alm AA, Larsson E, Adolfsson U. A prospective, randomized clinical study on the effects of an amine fluoride/stannous fluoride toothpaste/mouthrinse on plaque, gingivitis and initial caries lesion development in orthodontic patients. Eur J Orthod. 2006 Feb;28(1):8-12. Epub 2005 Oct 17.</citation>
    <PMID>16230329</PMID>
  </results_reference>
  <results_reference>
    <citation>Andersson A, SkÃ¶ld-Larsson K, Hallgren A, Petersson LG, Twetman S. Effect of a dental cream containing amorphous cream phosphate complexes on white spot lesion regression assessed by laser fluorescence. Oral Health Prev Dent. 2007;5(3):229-33.</citation>
    <PMID>17977295</PMID>
  </results_reference>
  <results_reference>
    <citation>Beerens MW, van der Veen MH, van Beek H, ten Cate JM. Effects of casein phosphopeptide amorphous calcium fluoride phosphate paste on white spot lesions and dental plaque after orthodontic treatment: a 3-month follow-up. Eur J Oral Sci. 2010 Dec;118(6):610-7. doi: 10.1111/j.1600-0722.2010.00780.x.</citation>
    <PMID>21083623</PMID>
  </results_reference>
  <results_reference>
    <citation>Reynolds EC. Remineralization of enamel subsurface lesions by casein phosphopeptide-stabilized calcium phosphate solutions. J Dent Res. 1997 Sep;76(9):1587-95.</citation>
    <PMID>9294493</PMID>
  </results_reference>
  <results_reference>
    <citation>Oshiro M, Yamaguchi K, Takamizawa T, Inage H, Watanabe T, Irokawa A, Ando S, Miyazaki M. Effect of CPP-ACP paste on tooth mineralization: an FE-SEM study. J Oral Sci. 2007 Jun;49(2):115-20.</citation>
    <PMID>17634723</PMID>
  </results_reference>
  <results_reference>
    <citation>Sudjalim TR, Woods MG, Manton DJ, Reynolds EC. Prevention of demineralization around orthodontic brackets in vitro. Am J Orthod Dentofacial Orthop. 2007 Jun;131(6):705.e1-9.</citation>
    <PMID>17561043</PMID>
  </results_reference>
  <results_reference>
    <citation>Cai F, Shen P, Morgan MV, Reynolds EC. Remineralization of enamel subsurface lesions in situ by sugar-free lozenges containing casein phosphopeptide-amorphous calcium phosphate. Aust Dent J. 2003 Dec;48(4):240-3.</citation>
    <PMID>14738126</PMID>
  </results_reference>
  <results_reference>
    <citation>Uysal T, Amasyali M, Ozcan S, Koyuturk AE, Akyol M, Sagdic D. In vivo effects of amorphous calcium phosphate-containing orthodontic composite on enamel demineralization around orthodontic brackets. Aust Dent J. 2010 Sep;55(3):285-91. doi: 10.1111/j.1834-7819.2010.01236.x.</citation>
    <PMID>20887516</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang JX, Yan Y, Wang XJ. Clinical evaluation of remineralization potential of casein phosphopeptide amorphous calcium phosphate nanocomplexes for enamel decalcification in orthodontics. Chin Med J (Engl). 2012 Nov;125(22):4018-21.</citation>
    <PMID>23158136</PMID>
  </results_reference>
  <results_reference>
    <citation>Robertson MA, Kau CH, English JD, Lee RP, Powers J, Nguyen JT. MI Paste Plus to prevent demineralization in orthodontic patients: a prospective randomized controlled trial. Am J Orthod Dentofacial Orthop. 2011 Nov;140(5):660-8. doi: 10.1016/j.ajodo.2010.10.025.</citation>
    <PMID>22051486</PMID>
  </results_reference>
  <results_reference>
    <citation>Huang GJ, Roloff-Chiang B, Mills BE, Shalchi S, Spiekerman C, Korpak AM, Starrett JL, Greenlee GM, Drangsholt RJ, Matunas JC. Effectiveness of MI Paste Plus and PreviDent fluoride varnish for treatment of white spot lesions: a randomized controlled trial. Am J Orthod Dentofacial Orthop. 2013 Jan;143(1):31-41. doi: 10.1016/j.ajodo.2012.09.007.</citation>
    <PMID>23273358</PMID>
  </results_reference>
  <results_reference>
    <citation>Bader JD. Casein phosphopeptide-amorphous calcium phosphate shows promise for preventing caries. Evid Based Dent. 2010;11(1):11-2. doi: 10.1038/sj.ebd.6400701.</citation>
    <PMID>20348890</PMID>
  </results_reference>
  <results_reference>
    <citation>Nyvad B, Machiulskiene V, Baelum V. Reliability of a new caries diagnostic system differentiating between active and inactive caries lesions. Caries Res. 1999 Jul-Aug;33(4):252-60.</citation>
    <PMID>10343087</PMID>
  </results_reference>
  <results_reference>
    <citation>Terrer E, Koubi S, Dionne A, Weisrock G, Sarraquigne C, Mazuir A, Tassery H. A new concept in restorative dentistry: light-induced fluorescence evaluator for diagnosis and treatment. Part 1: Diagnosis and treatment of initial occlusal caries. J Contemp Dent Pract. 2009 Nov 1;10(6):E086-94.</citation>
    <PMID>20020086</PMID>
  </results_reference>
  <results_reference>
    <citation>Rechmann P, Charland D, Rechmann BM, Featherstone JD. Performance of laser fluorescence devices and visual examination for the detection of occlusal caries in permanent molars. J Biomed Opt. 2012 Mar;17(3):036006. doi: 10.1117/1.JBO.17.3.036006.</citation>
    <PMID>22502564</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2015</study_first_submitted>
  <study_first_submitted_qc>April 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2015</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Peter Rechmann</investigator_full_name>
    <investigator_title>DMD, PhD, Prof. Dr. med. dent</investigator_title>
  </responsible_party>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Caries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Sodium Fluoride</mesh_term>
    <mesh_term>Fluorides, Topical</mesh_term>
    <mesh_term>Listerine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

